Auteur M. VERDENIK

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Nouveauté

Beyond the test: employee perspectives on the characteristics of drug checking services

I. KVATERNIK ; M. VERDENIK ; M. SANDE | 2026
Dans Drugs, Habits and Social Policy (Vol.27, n°2, 16 June 2026) Article : Périodique

Purpose: This study aims to examine the perspectives of employees involved in drug checking services (DCS) in Slovenia, focusing on sample collection points for illicit drugs and new psychoactive substances (NPS). As part of the national harm re[...]

Plus d'info

Ajouter à la sélection

Lien externe

'I will not use it because the results are bad' - Understanding the influence of the drug checking service on changing consumption behavior

M. VERDENIK ; S. ROLANDO ; M. SANDE | 2025
Dans Drugs: Education, Prevention and Policy (Vol.32, n°6, December 2025) Article : Périodique

Background: Based on the theories of reasoned action and planned behavior, this study aimed to investigate the impact of drug checking services (DCS) on clients' consumption behavior and to assess the intention to use drugs based on DC results, [...]

Plus d'info

Ajouter à la sélection

Lien externe

Size matters: comparing the MDMA content and weight of ecstasy tablets submitted to European drug checking services in 2012-2021

R. Q. VROLIJK ; F. MEASHAM ; A. QUESADA ; A. LUF ; D. SCHORI ; S. RADLEY ; D. ACREMAN ; J. SMITH ; M. VERDENIK ; D. MARTINS ; M. CUNHA ; C. J. PAULOS ; I. F. PICCININ ; E. GERACE ; A. KARDEN ; R. P. J. KONING ; L. A. SMIT-RIGTER ; M. VENTURA | 2022
Dans Drugs, Habits and Social Policy (Vol.23, n°3, 2022) Article : Périodique

Purpose: The 3,4-methylenedioxymetamphetamine (MDMA) content in ecstasy tablets has increased enormously throughout Europe across the past decade. This study aims to determine whether this is caused by the production of "stronger" tablets (more [...]

Plus d'info

Ajouter à la sélection

Lien externe